Hotspot mutations in BRAF and NRAS define the two major subtypes of melanoma that are mutually exclusive, with 50% of patients harboring BRAFV600E mutations and 30% of patients harboring NRAS hotspot mutations (Cancer Genome Atlas Network, 2015a). The gene discussed is NRAS; the disease is melanoma.